| Sent on February 14, 2008 | SAMHSA Health Information Network | eNetwork Archives |
New DASIS Report: Primary Methamphetamine/Amphetamine Admissions to Substance Abuse Treatment: 2005
Methamphetamine and amphetamines are highly addictive central nervous system stimulants. Methamphetamine and amphetamine abuse can lead to serious health consequences, such as rapid or irregular heartbeats, dental problems, mood disturbances, impaired memory, and chronic psychiatric problems. From 1995 to 2005, the percentage of substance abuse treatment admissions for primary abuse of methamphetamine/amphetamine more than doubled from 4 percent to 9 percent.
This report examines the characteristics of substance abuse treatment admissions in which methamphetamine/amphetamine was the primary substance of abuse and compares them with admissions in which other substances were primary.
The following are brief findings found in the report:
- In 2005, 169,500 admissions were for primary methamphetamine/amphetamine abuse, representing 9 percent of all admissions
- Primary methamphetamine/amphetamine admissions were more likely to be female than admissions for other primary substances (46 vs. 31 percent)
- The criminal justice system was the principal source of referral for 49 percent of primary methamphetamine/amphetamine admissions compared with 34 percent of other admissions
Download DASIS Report:
Primary Methamphetamine/Ampehtamine Admissions to Substance Abuse Treatment: 2005
(493 KB)
- Office of Applied Studies
- Reports and Fact Sheets on Drug and Alcohol Treatment Services
- Substance Abuse Treatment Facility Locator
